Market Place
Sourcing Support
All News #Library
Biotech
Citius Oncology Updates on LYMPHIR™ Launch and Pipeline Expansion
31 Mar 2026 //
PR NEWSWIRE
Citius Pharma Reports First Revenue After LYMPHIR Launch
13 Feb 2026 //
PR NEWSWIRE
Citius Oncology Launches LYMPHIR for CTCL in U.S
01 Dec 2025 //
PR NEWSWIRE
Citius Oncology to Showcase Pipeline at 67th ASH Meeting
25 Nov 2025 //
PR NEWSWIRE
Citius Oncology Advances LYMPHIR™ Commercial Launch With Verix
21 Nov 2025 //
PR NEWSWIRE BIO
Citius Oncology Use AI to Boost Performance Before LYMPHIR Launch
23 Aug 2025 //
PR NEWSWIRE
Citius Pharma Announces Promising Pembrolizumab Trial Results
11 Nov 2024 //
PR NEWSWIRE
Citius Announces FDA Acceptance of the BLA Resubmission of LYMPHIR for CTCL
18 Mar 2024 //
PR NEWSWIRE
Citius Pharmaceuticals Resubmits the Biologics License Application of LYMPHIR
14 Feb 2024 //
PR NEWSWIRE
Citius Receives Regulatory Guidance from FDA regarding BLA for LYMPHIR
08 Sep 2023 //
PR NEWSWIRE
Citius Advances Efforts to Spin Off Oncology Asset
30 Mar 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.